Previous close | 96.22 |
Open | 96.12 |
Bid | 96.58 x 0 |
Ask | 96.88 x 0 |
Day's range | 95.80 - 96.96 |
52-week range | 72.28 - 105.90 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The U.S. health regulator has sent a warning letter to Cardinal Health after an inspection of its facility in Illinois found the company was marketing and distributing unapproved devices made by a Chinese manufacturer. The U.S. Food and Drug Administration in 2023 recommended against the use of some China-made syringes as it investigated reports of leaks, breakages and other quality problems with such products and last month expanded the guidance. Cardinal did not immediately respond to a Reuters request for comment.
Super Micro Computer's (SMCI) third-quarter fiscal 2024 performance will likely reflect strength in the Server & Storage Systems and Subsystems & Accessories segments.
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.